Purchase Order 75N90019P00055

<p>The NIH Clinical Center awarded a purchase order to Research and Diagnostic Systems, Inc. for $16,456.50 on November 14, 2019, with completion by November 28, 2019. Place of performance is Minneapolis, Minnesota. The order covers biological research materials and reagents, including recombinant human proteins, antibodies, ELISA kits, cytokine assays, and fetal bovine serum supporting biomedical research. Pricing is firm fixed price with no set-aside used.</p>

The NIH Clinical Center awarded a purchase order to Research And Diagnostic Systems, Inc. for $29,103.00 on March 27, 2019, with completion scheduled for April 30, 2019. No set-aside was used. Performance occurs in Bethesda, Maryland. The purchase order procures biological research materials and reagents—the company supplies recombinant human proteins, antibodies, ELISA kits, cytokine assays, fetal bovine serum, and specialized laboratory supplies supporting biomedical research across NIH...

The NIH Clinical Center awarded a purchase order to Research and Diagnostic Systems, Inc. valued at $9,325.35 on July 16, 2019, with performance completion targeted for July 31, 2019. The order is firm-fixed-price, issued under no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures biological research materials and laboratory supplies—including recombinant proteins, antibodies, ELISA kits, and specialized reagents—from R&amp;D Systems' established product catalog...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,250.50 firm fixed price purchase order to Research And Diagnostic Systems, Inc., doing business as R&amp;D Systems, a division of Bio-Techne Corporation. The contract is for research and development reagents to be delivered from October 17, 2023 through November 6, 2023. As the prime contractor, R&amp;D Systems will provide laboratory supplies and materials to support the NIH Clinical Center's...

The NIH Clinical Center awarded a purchase order to Research And Diagnostic Systems, Inc. for $11,150.10 on April 23, 2020. The order covers human ACE-2 antibody, human EMMPRIN/DC147 antibody, human adhesion molecule magnetic Luminex performance assay, and human magnetic Luminex assay materials. Place of performance is Minneapolis, Minnesota. The award was designated under the National Interest Action Code for Coronavirus COVID-19 and was issued at firm fixed price with no small business...

The National Cancer Institute awarded a purchase order to Research And Diagnostic Systems, Inc. for $10,893.70 on December 15, 2020, for biological and reagent material, with completion on January 8, 2021. Place of performance is Minneapolis, Minnesota. The order carries no set-aside designation and is priced firm fixed price. Research And Diagnostic Systems, a for-profit manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, supplies recombinant human...

This purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Research and Diagnostic Systems, Inc. is valued at $445,214.70 to deliver 89 items including 27 types of recombinant human proteins and 12 small molecule compounds by June 30, 2021. As the sole source provider, Research and Diagnostic Systems will ship the products from its Minneapolis location within 14 days of each order to support the Center's consistent research...

<p>The National Institute of Dental and Craniofacial Research awarded a purchase order to Research and Diagnostic Systems, Inc. for $13,305.90 on August 25, 2020. The order calls for IL-17RC antibody to be delivered to Minneapolis, Minnesota, with an ultimate completion date of August 31, 2020. Pricing is firm fixed price. No set-aside was used.</p>

<p>NIH Clinical Center awarded a purchase order to Advanced Cell Diagnostics, Inc. for $16,662.30 on May 17, 2018, to cover setup fees for new target probe RNAscopes and related accessories and shipping. Place of performance is Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of May 25, 2018. No set-aside was used.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $24,045.00 firm fixed price purchase order to Research And Diagnostic Systems, Inc. (R&amp;D Systems) for custom protein development services. R&amp;D Systems is a for-profit manufacturer of antibodies, ELISA kits, proteins, and other research materials that has provided a range of products and services to various HHS agencies, including the NIH, Centers...